Trials

official impact factor 2.08

Open Access Highly Access Study protocol

Prophylactic antibiotic for prevention of posttraumatic meningitis after traumatic pneumocephalus: design and rationale of a placebo-controlled randomized multicenter trial [ISRCTN71132784]

Behzad Eftekhar1*, Mohammad Ghodsi1, Azar Hadadi2, Mousa Taghipoor3, Samira Z Sigarchi4, Vafa Rahimi-Movaghar5, Ehsan S Kazemzadeh3, Babak Esmaeeli7, Farideh Nejat8, Alireza Yalda6 and Ebrahim Ketabchi1

Author Affiliations

1 Sina Trauma and Surgery Research Center and Department of Neurosurgery, Sina Hospital, Tehran University, Iran

2 Department of Infectious Diseases, Sina Hospital, Tehran University, Iran

3 Department of Neurosurgery, Namazi Hospital, Shiraz University, Iran

4 Department of Neurosurgery, Ghaem Hospital, Mashad University, Iran

5 Department of Neurosurgery, Khatam-ol-anbia Hospital, Zahedan University, Iran

6 Department of Infectious Diseases, Imam Hospital, Tehran University, Iran

7 Department of Neurosurgery, Hospital, Shahrood, Iran

8 Department of Neurosurgery, Children's Hospital Medical Center, Tehran University, Iran

For all author emails, please log on.

Trials 2006, 7:2 doi:10.1186/1745-6215-7-2

Published: 18 January 2006

Abstract

Background

The purpose of this study is to compare the efficacy of prophylactic antibiotic for prevention of meningitis in acute traumatic pneumocephalus patients.

Methods

In this prospective, randomized controlled clinical trial, 200 selected head injury patients with traumatic pneumocephalus are randomly assigned to receive intravenous antibiotics (2 grams Ceftriaxone twice a day), oral antibiotics (Azithromycin) or placebo for at least 7 days after trauma. The patients will be followed for one month posttrauma.

Conclusion

The authors hope that this study helps clarifying the effectiveness and indications of antibiotics in prevention of meningitis in traumatic pneumocephalus after head injury and in specific subgroup of these patients.